JOHN JOHNSON: Open Payments
NPI 1043650641 · YARMOUTH PORT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,480 in 93 payments from 21 companies in 2025. Trend: 2023 $1,584 · 2024 $2,502 · 2025 $2,480
Food & beverage: $2,359Education: $121
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 28 | $809 |
| Regeneron Healthcare Solutions, Inc. | 16 | $527 |
| Novartis Pharmaceuticals Corporation | 10 | $161 |
| GlaxoSmithKline, LLC. | 4 | $126 |
| Grifols USA, LLC | 5 | $121 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $119 |
| GENZYME CORPORATION | 3 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Pharming Healthcare, Inc. | 3 | $72 |
| BioCryst US Sales Co., LLC | 2 | $56 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, FASENRA, NUCALA, NEFFY, Xolair, TUDORZA PRESSAIR.
Industry payments across MA — which companies pay providers there.
